Donley Matthew Maxwell bought AUPH
February 27, 2026 · Form 4 insider transaction
Donley Matthew Maxwell bought 97,256 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
97,256
Price
$0.00
Total value
N/A
InsiderDonley Matthew Maxwell
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after97,256
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.